Cargando…

A pref-1-controlled non-inflammatory mechanism of insulin resistance

While insulin resistance (IR) is associated with inflammation in white adipose tissue, we report a non-inflammatory adipose mechanism of high fat-induced IR mediated by loss of Pref-1. Pref-1, released from adipose Pref-1+ cells with characteristics of M2 macrophages, endothelial cells or progenitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yiheng, Cui, Donghong, Chen, Liujun, Tong, Haibin, Wu, Hong, Muller, Grace K., Qi, Yadan, Wang, Shuxia, Xu, Jinjie, Gao, Xiang, Fifield, Kathleen E., Wang, Lingyan, Xia, Zhengyuan, Vanderluit, Jacqueline L., Liu, Suixin, Leng, Lin, Sun, Guang, McGuire, John, Young, Lawrence H., Bucala, Richard, Qi, Dake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239698/
https://www.ncbi.nlm.nih.gov/pubmed/37283810
http://dx.doi.org/10.1016/j.isci.2023.106923
_version_ 1785053545780740096
author Huang, Yiheng
Cui, Donghong
Chen, Liujun
Tong, Haibin
Wu, Hong
Muller, Grace K.
Qi, Yadan
Wang, Shuxia
Xu, Jinjie
Gao, Xiang
Fifield, Kathleen E.
Wang, Lingyan
Xia, Zhengyuan
Vanderluit, Jacqueline L.
Liu, Suixin
Leng, Lin
Sun, Guang
McGuire, John
Young, Lawrence H.
Bucala, Richard
Qi, Dake
author_facet Huang, Yiheng
Cui, Donghong
Chen, Liujun
Tong, Haibin
Wu, Hong
Muller, Grace K.
Qi, Yadan
Wang, Shuxia
Xu, Jinjie
Gao, Xiang
Fifield, Kathleen E.
Wang, Lingyan
Xia, Zhengyuan
Vanderluit, Jacqueline L.
Liu, Suixin
Leng, Lin
Sun, Guang
McGuire, John
Young, Lawrence H.
Bucala, Richard
Qi, Dake
author_sort Huang, Yiheng
collection PubMed
description While insulin resistance (IR) is associated with inflammation in white adipose tissue, we report a non-inflammatory adipose mechanism of high fat-induced IR mediated by loss of Pref-1. Pref-1, released from adipose Pref-1+ cells with characteristics of M2 macrophages, endothelial cells or progenitors, inhibits MIF release from both Pref-1+ cells and adipocytes by binding with integrin β1 and inhibiting the mobilization of p115. High palmitic acid induces PAR2 expression in Pref-1+ cells, downregulating Pref-1 expression and release in an AMPK-dependent manner. The loss of Pref-1 increases adipose MIF secretion contributing to non-inflammatory IR in obesity. Treatment with Pref-1 blunts the increase in circulating plasma MIF levels and subsequent IR induced by a high palmitic acid diet. Thus, high levels of fatty acids suppress Pref-1 expression and secretion, through increased activation of PAR2, resulting in an increase in MIF secretion and a non-inflammatory adipose mechanism of IR.
format Online
Article
Text
id pubmed-10239698
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102396982023-06-06 A pref-1-controlled non-inflammatory mechanism of insulin resistance Huang, Yiheng Cui, Donghong Chen, Liujun Tong, Haibin Wu, Hong Muller, Grace K. Qi, Yadan Wang, Shuxia Xu, Jinjie Gao, Xiang Fifield, Kathleen E. Wang, Lingyan Xia, Zhengyuan Vanderluit, Jacqueline L. Liu, Suixin Leng, Lin Sun, Guang McGuire, John Young, Lawrence H. Bucala, Richard Qi, Dake iScience Article While insulin resistance (IR) is associated with inflammation in white adipose tissue, we report a non-inflammatory adipose mechanism of high fat-induced IR mediated by loss of Pref-1. Pref-1, released from adipose Pref-1+ cells with characteristics of M2 macrophages, endothelial cells or progenitors, inhibits MIF release from both Pref-1+ cells and adipocytes by binding with integrin β1 and inhibiting the mobilization of p115. High palmitic acid induces PAR2 expression in Pref-1+ cells, downregulating Pref-1 expression and release in an AMPK-dependent manner. The loss of Pref-1 increases adipose MIF secretion contributing to non-inflammatory IR in obesity. Treatment with Pref-1 blunts the increase in circulating plasma MIF levels and subsequent IR induced by a high palmitic acid diet. Thus, high levels of fatty acids suppress Pref-1 expression and secretion, through increased activation of PAR2, resulting in an increase in MIF secretion and a non-inflammatory adipose mechanism of IR. Elsevier 2023-05-19 /pmc/articles/PMC10239698/ /pubmed/37283810 http://dx.doi.org/10.1016/j.isci.2023.106923 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Huang, Yiheng
Cui, Donghong
Chen, Liujun
Tong, Haibin
Wu, Hong
Muller, Grace K.
Qi, Yadan
Wang, Shuxia
Xu, Jinjie
Gao, Xiang
Fifield, Kathleen E.
Wang, Lingyan
Xia, Zhengyuan
Vanderluit, Jacqueline L.
Liu, Suixin
Leng, Lin
Sun, Guang
McGuire, John
Young, Lawrence H.
Bucala, Richard
Qi, Dake
A pref-1-controlled non-inflammatory mechanism of insulin resistance
title A pref-1-controlled non-inflammatory mechanism of insulin resistance
title_full A pref-1-controlled non-inflammatory mechanism of insulin resistance
title_fullStr A pref-1-controlled non-inflammatory mechanism of insulin resistance
title_full_unstemmed A pref-1-controlled non-inflammatory mechanism of insulin resistance
title_short A pref-1-controlled non-inflammatory mechanism of insulin resistance
title_sort pref-1-controlled non-inflammatory mechanism of insulin resistance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239698/
https://www.ncbi.nlm.nih.gov/pubmed/37283810
http://dx.doi.org/10.1016/j.isci.2023.106923
work_keys_str_mv AT huangyiheng apref1controllednoninflammatorymechanismofinsulinresistance
AT cuidonghong apref1controllednoninflammatorymechanismofinsulinresistance
AT chenliujun apref1controllednoninflammatorymechanismofinsulinresistance
AT tonghaibin apref1controllednoninflammatorymechanismofinsulinresistance
AT wuhong apref1controllednoninflammatorymechanismofinsulinresistance
AT mullergracek apref1controllednoninflammatorymechanismofinsulinresistance
AT qiyadan apref1controllednoninflammatorymechanismofinsulinresistance
AT wangshuxia apref1controllednoninflammatorymechanismofinsulinresistance
AT xujinjie apref1controllednoninflammatorymechanismofinsulinresistance
AT gaoxiang apref1controllednoninflammatorymechanismofinsulinresistance
AT fifieldkathleene apref1controllednoninflammatorymechanismofinsulinresistance
AT wanglingyan apref1controllednoninflammatorymechanismofinsulinresistance
AT xiazhengyuan apref1controllednoninflammatorymechanismofinsulinresistance
AT vanderluitjacquelinel apref1controllednoninflammatorymechanismofinsulinresistance
AT liusuixin apref1controllednoninflammatorymechanismofinsulinresistance
AT lenglin apref1controllednoninflammatorymechanismofinsulinresistance
AT sunguang apref1controllednoninflammatorymechanismofinsulinresistance
AT mcguirejohn apref1controllednoninflammatorymechanismofinsulinresistance
AT younglawrenceh apref1controllednoninflammatorymechanismofinsulinresistance
AT bucalarichard apref1controllednoninflammatorymechanismofinsulinresistance
AT qidake apref1controllednoninflammatorymechanismofinsulinresistance
AT huangyiheng pref1controllednoninflammatorymechanismofinsulinresistance
AT cuidonghong pref1controllednoninflammatorymechanismofinsulinresistance
AT chenliujun pref1controllednoninflammatorymechanismofinsulinresistance
AT tonghaibin pref1controllednoninflammatorymechanismofinsulinresistance
AT wuhong pref1controllednoninflammatorymechanismofinsulinresistance
AT mullergracek pref1controllednoninflammatorymechanismofinsulinresistance
AT qiyadan pref1controllednoninflammatorymechanismofinsulinresistance
AT wangshuxia pref1controllednoninflammatorymechanismofinsulinresistance
AT xujinjie pref1controllednoninflammatorymechanismofinsulinresistance
AT gaoxiang pref1controllednoninflammatorymechanismofinsulinresistance
AT fifieldkathleene pref1controllednoninflammatorymechanismofinsulinresistance
AT wanglingyan pref1controllednoninflammatorymechanismofinsulinresistance
AT xiazhengyuan pref1controllednoninflammatorymechanismofinsulinresistance
AT vanderluitjacquelinel pref1controllednoninflammatorymechanismofinsulinresistance
AT liusuixin pref1controllednoninflammatorymechanismofinsulinresistance
AT lenglin pref1controllednoninflammatorymechanismofinsulinresistance
AT sunguang pref1controllednoninflammatorymechanismofinsulinresistance
AT mcguirejohn pref1controllednoninflammatorymechanismofinsulinresistance
AT younglawrenceh pref1controllednoninflammatorymechanismofinsulinresistance
AT bucalarichard pref1controllednoninflammatorymechanismofinsulinresistance
AT qidake pref1controllednoninflammatorymechanismofinsulinresistance